Midrange Testosterone Levels Optimal for Older Men

Published Online: Friday, January 17, 2014
Follow Pharmacy_Times:
Older men with moderate natural testosterone levels may be more likely to live longer than those with the highest and lowest levels, a new study suggests.

The researchers of the study measured testosterone, dihydrotestosterone, and estradiol levels in men 70 to 89 years of age and assessed the risks for all-cause and ischemic heart disease mortality. Baseline blood samples were collected in the morning between 2001 and 2004 and were analyzed using liquid chromatography-tandem mass spectrometry.

The researchers followed 3690 men, recording deaths until December 2010. The results were published online on November 20, 2013, in The Journal of Clinical Endocrinology & Metabolism.

Overall, 26.4% of participants died throughout the study period. When separated into 4 groups based on testosterone levels, 23.3% to 25.1% of men in the middle quartiles died, compared with 30.8% of men with the lowest levels and 26.5% of men with the highest levels.

After other risk factors were adjusted for, both testosterone and dihydrotestosterone were associated with all-cause mortality. Higher levels of dihydrotestosterone were associated with a reduced risk for death caused by ischemic heart disease. There was not a relationship between estradiol and all-cause or heart disease mortality.

The study did not include men taking testosterone supplements, and the authors note that more research is needed to study the effects of hormone therapy in men.

Related Articles
Mylan Inc. has announced the US launch of its estradiol transdermal system, the generic version of Novartis' Vivelle-DOT.
Contrary to previous evidence, a new study published in The Journal of Urology found that long-term testosterone therapy does not increase the risk of prostate cancer in men with hypogonadism.
The American Heart Association awarded its Clinical Research Prize for 2014 to Judith S. Hochman, M.D., of NYU Langone Medical Center “for exceptional leadership of landmark clinical trials profoundly impacting formulation of national practice guidelines for the management of ischemic heart disease.”
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$